| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
14,736 |
13,425 |
$1.22M |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
2,336 |
2,283 |
$1.02M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
3,219 |
2,961 |
$341K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
1,253 |
1,252 |
$135K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
1,307 |
1,305 |
$126K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
896 |
876 |
$123K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
1,035 |
991 |
$111K |
| 87640 |
|
1,786 |
1,750 |
$74K |
| 87581 |
|
1,808 |
1,771 |
$71K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
1,775 |
1,738 |
$69K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
2,833 |
2,773 |
$63K |
| 87641 |
|
1,459 |
1,428 |
$61K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
1,609 |
1,595 |
$58K |
| 87498 |
|
1,365 |
1,339 |
$58K |
| 87486 |
|
1,364 |
1,338 |
$56K |
| 87541 |
|
1,360 |
1,333 |
$56K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
843 |
835 |
$43K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
305 |
300 |
$43K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
382 |
381 |
$42K |
| 99383 |
|
221 |
220 |
$39K |
| 87481 |
|
203 |
202 |
$35K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
235 |
235 |
$33K |
| 99382 |
|
176 |
174 |
$31K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,604 |
794 |
$28K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,478 |
1,458 |
$25K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
895 |
785 |
$17K |
| 87529 |
|
197 |
197 |
$14K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
115 |
114 |
$12K |
| 99381 |
|
63 |
63 |
$11K |
| 90686 |
|
486 |
484 |
$11K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
619 |
619 |
$10K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
70 |
70 |
$8K |
| 99384 |
|
42 |
42 |
$8K |
| 87653 |
|
201 |
200 |
$7K |
| 90474 |
|
333 |
333 |
$7K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
193 |
193 |
$7K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
194 |
194 |
$7K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
194 |
194 |
$7K |
| 87511 |
|
193 |
193 |
$7K |
| 88142 |
|
320 |
319 |
$6K |
| 95117 |
|
472 |
167 |
$6K |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
417 |
376 |
$6K |
| 99385 |
|
26 |
26 |
$5K |
| 87807 |
|
109 |
107 |
$1K |
| 90672 |
|
41 |
41 |
$1K |
| 87428 |
|
14 |
14 |
$872.94 |
| 90473 |
|
28 |
28 |
$607.65 |
| 90715 |
|
14 |
14 |
$430.17 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
131 |
130 |
$253.18 |
| 81025 |
|
13 |
13 |
$103.67 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
37 |
37 |
$51.08 |
| 90633 |
|
480 |
478 |
$4.29 |
| 90670 |
|
433 |
433 |
$3.95 |
| 90648 |
|
429 |
429 |
$3.93 |
| 90710 |
|
418 |
416 |
$3.79 |
| 90698 |
|
292 |
291 |
$2.72 |
| 90671 |
|
248 |
247 |
$2.48 |
| 90681 |
|
173 |
173 |
$1.65 |
| 90677 |
|
123 |
123 |
$1.23 |
| 90723 |
|
124 |
124 |
$1.13 |
| 90700 |
|
82 |
82 |
$0.72 |
| 90696 |
|
67 |
67 |
$0.65 |
| 90744 |
|
42 |
42 |
$0.41 |
| 90651 |
|
34 |
34 |
$0.34 |
| 90734 |
|
35 |
33 |
$0.29 |
| 90680 |
|
12 |
12 |
$0.12 |